|
1
|
Lorentzon M and Cummings SR: Osteoporosis:
The evolution of a diagnosis. J Intern Med. 277:650–661. 2015.
|
|
2
|
Salari N, Ghasemi H, Mohammadi L, Behzadi
MH, Rabieenia E, Shohaimi S and Mohammadi M: The global prevalence
of osteoporosis in the world: A comprehensive systematic review and
meta-analysis. J Orthop Surg Res. 16:6092021.
|
|
3
|
Xiao PL, Cui AY, Hsu CJ, Peng R, Jiang N,
Xu XH, Ma YG, Liu D and Lu HD: Global, regional prevalence, and
risk factors of osteoporosis according to the World Health
Organization diagnostic criteria: A systematic review and
meta-analysis. Osteoporos Int. 33:2137–2153. 2022.
|
|
4
|
Clynes MA, Harvey NC, Curtis EM, Fuggle
NR, Dennison EM and Cooper C: The epidemiology of osteoporosis. Br
Med Bull. 133:105–117. 2020.
|
|
5
|
Pouresmaeili F, Kamalidehghan B, Kamarehei
M and Goh YM: A comprehensive overview on osteoporosis and its risk
factors. Ther Clin Risk Manag. 14:2029–2049. 2018.
|
|
6
|
Levis S and Lagari VS: The role of diet in
osteoporosis prevention and management. Curr Osteoporos Rep.
10:296–302. 2012.
|
|
7
|
Muñoz-Garach A, García-Fontana B and
Muñoz-Torres M: Nutrients and dietary patterns related to
osteoporosis. Nutrients. 12:19862020.
|
|
8
|
Brincat M, Gambin J, Brincat M and
Calleja-Agius J: The role of vitamin D in osteoporosis. Maturitas.
80:329–332. 2015.
|
|
9
|
Goltzman D: Functions of vitamin D in
bone. Histochem Cell Biol. 149:305–312. 2018.
|
|
10
|
Ratajczak AE, Rychter AM, Zawada A,
Dobrowolska A and Krela-Kaźmierczak I: Do only calcium and vitamin
D matter? Micronutrients in the diet of inflammatory bowel diseases
patients and the risk of osteoporosis. Nutrients. 13:5252021.
|
|
11
|
Martiniakova M, Babikova M, Mondockova V,
Blahova J, Kovacova V and Omelka R: The role of macronutrients,
micronutrients and flavonoid polyphenols in the prevention and
treatment of osteoporosis. Nutrients. 14:5232022.
|
|
12
|
Heaney RP: Nutrition and risk for
osteoporosis. Osteoporosis. Acadmic Press; pp. 669–700. 2001
|
|
13
|
Nazrun AS, Norazlina M, Norliza M and
Nirwana SI: Comparison of the effects of tocopherol and tocotrienol
on osteoporosis in animal models. Int J Pharmacol. 6:561–568.
2010.
|
|
14
|
Wu AM, Huang CQ, Lin ZK, Tian NF, Ni WF,
Wang XY, Xu HZ and Chi YL: The relationship between vitamin A and
risk of fracture: Meta-analysis of prospective studies. J Bone
Miner Res. 29:2032–2039. 2014.
|
|
15
|
Henning P, Conaway HH and Lerner UH:
Retinoid receptors in bone and their role in bone remodeling. Front
Endocrinol (Lausanne). 6:312015.
|
|
16
|
Ahmadieh H and Arabi A: Vitamins and bone
health: Beyond calcium and vitamin D. Nutr Rev. 69:584–598.
2011.
|
|
17
|
Szewczyk K, Chojnacka A and Górnicka M:
Tocopherols and tocotrienols-bioactive dietary compounds; What is
certain, what is doubt? Int J Mol Sci. 22:62222021.
|
|
18
|
Wong SK, Mohamad NV, Ibrahim N', Chin KY,
Shuid AN and Ima-Nirwana S: The molecular mechanism of vitamin E as
a bone-protecting agent: A review on current evidence. Int J Mol
Sci. 20:14532019.
|
|
19
|
Michaëlsson K and Larsson SC: Circulating
alpha-tocopherol levels, bone mineral density, and fracture:
Mendelian randomization study. Nutrients. 13:19402021.
|
|
20
|
Mata-Granados JM, Cuenca-Acebedo R, Luque
de Castro MD and Quesada Gómez JM: Lower vitamin E serum levels are
associated with osteoporosis in early postmenopausal women: A
cross-sectional study. J Bone Miner Metab. 31:455–460. 2013.
|
|
21
|
Holvik K, Gjesdal CG, Tell GS, Grimnes G,
Schei B, Apalset EM, Samuelsen SO, Blomhoff R, Michaëlsson K and
Meyer HE: Low serum concentrations of alpha-tocopherol are
associated with increased risk of hip fracture. A NOREPOS study.
Osteoporos Int. 25:2545–2554. 2014.
|
|
22
|
Michaëlsson K, Wolk A, Byberg L, Ärnlöv J
and Melhus H: Intake and serum concentrations of α-tocopherol in
relation to fractures in elderly women and men: 2 Cohort studies.
Am J Clin Nutr. 99:107–114. 2014.
|
|
23
|
Shen CL, Yang S, Tomison MD, Romero AW,
Felton CK and Mo H: Tocotrienol supplementation suppressed bone
resorption and oxidative stress in postmenopausal osteopenic women:
A 12-week randomized double-blinded placebo-controlled trial.
Osteoporos Int. 29:881–891. 2018.
|
|
24
|
Vallibhakara SAO, Nakpalat K,
Sophonsritsuk A, Tantitham C and Vallibhakara O: Effect of vitamin
E supplement on bone turnover markers in postmenopausal osteopenic
women: A double-blind, randomized, placebo-controlled trial.
Nutrients. 13:42262021.
|
|
25
|
Yang TC, Duthie GG, Aucott LS and
Macdonald HM: Vitamin E homologues α- and γ-tocopherol are not
associated with bone turnover markers or bone mineral density in
peri-menopausal and post-menopausal women. Osteoporos Int.
27:2281–2290. 2016.
|
|
26
|
Zhang J, Hu X and Zhang J: Associations
between serum vitamin E concentration and bone mineral density in
the US elderly population. Osteoporos Int. 28:1245–1253. 2017.
|
|
27
|
Hampson G, Edwards S, Sankaralingam A,
Harrington DJ, Voong K, Fogelman I and Frost ML: Circulating
concentrations of vitamin E isomers: Association with bone turnover
and arterial stiffness in post-menopausal women. Bone. 81:407–412.
2015.
|
|
28
|
Hamidi MS, Corey PN and Cheung AM: Effects
of vitamin E on bone turnover markers among US postmenopausal
women. J Bone Miner Res. 27:1368–1380. 2012.
|
|
29
|
Mehat MZ, Shuid AN, Mohamed N, Muhammad N
and Soelaiman IN: Beneficial effects of vitamin E isomer
supplementation on static and dynamic bone histomorphometry
parameters in normal male rats. J Bone Miner Metab. 28:503–509.
2010.
|
|
30
|
Muhammad N, Luke DA, Shuid AN, Mohamed N
and Soelaiman IN: Two different isomers of vitamin E prevent bone
loss in postmenopausal osteoporosis rat model. Evid Based
Complement Alternat Med. 2012:1615272012.
|
|
31
|
Chin KY, Gengatharan D, Mohd Nasru FS,
Khairussam RA, Ern SL, Aminuddin SA and Ima-Nirwana S: The effects
of annatto tocotrienol on bone biomechanical strength and bone
calcium content in an animal model of osteoporosis due to
testosterone deficiency. Nutrients. 8:8082016.
|
|
32
|
Shuid AN, Mohamad S, Muhammad N, Fadzilah
FM, Mokhtar SA, Mohamed N and Soelaiman IN: Effects of α-tocopherol
on the early phase of osteoporotic fracture healing. J Orthop Res.
29:1732–1738. 2011.
|
|
33
|
Mohamad S, Shuid AN, Mohamed N, Fadzilah
FM, Mokhtar SA, Abdullah S, Othman F, Suhaimi F, Muhammad N and
Soelaiman IN: The effects of alpha-tocopherol supplementation on
fracture healing in a postmenopausal osteoporotic rat model.
Clinics (São Paulo). 67:1077–1085. 2012.
|
|
34
|
Akçay H, Kuru K, Tatar B and Şimşek F:
Vitamin E promotes bone formation in a distraction osteogenesis
model. J Craniofac Surg. 30:2315–2318. 2019.
|
|
35
|
Kurklu M, Yildiz C, Kose O, Yurttas Y,
Karacalioglu O, Serdar M and Deveci S: Effect of alpha-tocopherol
on bone formation during distraction osteogenesis: A rabbit model.
J Orthop Traumatol. 12:153–158. 2011.
|
|
36
|
Hagan ML, Bahraini A, Pierce JL, Bass SM,
Yu K, Elsayed R, Elsalanty M, Johnson MH, McNeil A, McNeil PL and
McGee-Lawrence ME: Inhibition of osteocyte membrane repair activity
via dietary vitamin E deprivation impairs osteocyte survival.
Calcif Tissue Int. 104:224–234. 2019.
|
|
37
|
Turan B, Can B and Delilbasi E: Selenium
combined with vitamin E and vitamin C restores structural
alterations of bones in heparin-induced osteoporosis. Clin
Rheumatol. 22:432–436. 2003.
|
|
38
|
Ikegami H, Kawawa R, Ichi I, Ishikawa T,
Koike T, Aoki Y and Fujiwara Y: Excessive vitamin E intake does not
cause bone loss in male or ovariectomized female mice fed normal or
high-fat diets. J Nutr. 147:1932–1937. 2017.
|
|
39
|
Kasai S, Ito A, Shindo K, Toyoshi T and
Bando M: High-dose α-tocopherol supplementation does not induce
bone loss in normal rats. PLoS One. 10:e01320592015.
|
|
40
|
Lan D, Yao C, Li X, Liu H, Wang D, Wang Y
and Qi S: Tocopherol attenuates the oxidative stress of BMSCs by
inhibiting ferroptosis through the PI3k/AKT/mTOR pathway. Front
Bioeng Biotechnol. 10:9385202022.
|
|
41
|
Ahn KH, Jung HK, Jung SE, Yi KW, Park HT,
Shin JH, Kim YT, Hur JY, Kim SH and Kim T: Microarray analysis of
gene expression during differentiation of human mesenchymal stem
cells treated with vitamin E in vitro into osteoblasts. Korean J
Bone Metab. 18:23–32. 2011.
|
|
42
|
Jia YB, Jiang DM, Ren YZ, Liang ZH, Zhao
ZQ and Wang YX: Inhibitory effects of vitamin E on osteocyte
apoptosis and DNA oxidative damage in bone marrow hemopoietic cells
at early stage of steroid-induced femoral head necrosis. Mol Med
Rep. 15:1585–1592. 2017.
|
|
43
|
Soeta S, Higuchi M, Yoshimura I, Itoh R,
Kimura N and Aamsaki H: Effects of vitamin E on the osteoblast
differentiation. J Vet Med Sci. 72:951–957. 2010.
|
|
44
|
Kim HN, Lee JH, Jin WJ and Lee ZH:
α-Tocopheryl succinate inhibits osteoclast formation by suppressing
receptor activator of nuclear factor-kappaB ligand (RANKL)
expression and bone resorption. J Bone Metab. 19:111–120. 2012.
|
|
45
|
Johnson SA, Feresin RG, Soungdo Y, Elam ML
and Arjmandi BH: Vitamin E suppresses ex vivo osteoclastogenesis in
ovariectomized rats. Food Funct. 7:1628–1633. 2016.
|
|
46
|
Fujita K, Iwasaki M, Ochi H, Fukuda T, Ma
C, Miyamoto T, Takitani K, Negishi-Koga T, Sunamura S, Kodama T, et
al: Vitamin E decreases bone mass by stimulating osteoclast fusion.
Nat Med. 18:589–594. 2012.
|
|
47
|
Chin KY and Ima-Nirwana S: The biological
effects of tocotrienol on bone: A review on evidence from rodent
models. Drug Des Devel Ther. 9:2049–2061. 2015.
|
|
48
|
Shen CL, Klein A, Chin KY, Mo H, Tsai P,
Yang RS, Chyu MC and Ima-Nirwana S: Tocotrienols for bone health: A
translational approach. Ann N Y Acad Sci. 1401:150–165. 2017.
|
|
49
|
Xu W, He P, He S, Cui P, Mi Y, Yang Y, Li
Y and Zhou S: Gamma-tocotrienol stimulates the proliferation,
differentiation, and mineralization in osteoblastic MC3T3-E1 cells.
J Chem. 2018:38059322018.
|
|
50
|
Wan Hasan WN, Abd Ghafar N, Chin KY and
Ima-Nirwana S: Annatto-derived tocotrienol stimulates osteogenic
activity in preosteoblastic MC3T3-E1 cells: A temporal sequential
study. Drug Des Devel Ther. 12:1715–1726. 2018.
|
|
51
|
Wan Hasan WN, Chin KY, Abd Ghafar N and
Soelaiman IN: Annatto-derived tocotrienol promotes mineralization
of MC3T3-E1 cells by enhancing BMP-2 protein expression via
inhibiting RhoA activation and HMG-CoA reductase gene expression.
Drug Des Devel Ther. 14:969–976. 2020.
|
|
52
|
Xu W, Li Y, Feng R, He P and Zhang Y:
γ-Tocotrienol induced the proliferation and differentiation of
MC3T3-E1 cells through the stimulation of the Wnt/β-catenin
signaling pathway. Food Funct. 13:398–410. 2022.
|
|
53
|
Shah AK and Yeganehjoo H: The stimulatory
impact of d-δ-Tocotrienol on the differentiation of murine MC3T3-E1
preosteoblasts. Mol Cell Biochem. 462:173–183. 2019.
|
|
54
|
Casati L, Pagani F, Maggi R, Ferrucci F
and Sibilia V: Food for bone: Evidence for a role for
delta-tocotrienol in the physiological control of osteoblast
migration. Int J Mol Sci. 21:46612020.
|
|
55
|
Abd Manan N, Mohamed N and Shuid AN:
Effects of low-dose versus high-dose γ-tocotrienol on the bone
cells exposed to the hydrogen peroxide-induced oxidative stress and
apoptosis. Evid Based Complement Alternat Med. 2012:6808342012.
|
|
56
|
Casati L, Pagani F, Limonta P, Vanetti C,
Stancari G and Sibilia V: Beneficial effects of δ-tocotrienol
against oxidative stress in osteoblastic cells: Studies on the
mechanisms of action. Eur J Nutr. 59:1975–1987. 2020.
|
|
57
|
Cai J, Tian X, Ren J, Lu S and Guo J:
Synergistic effect of sesamin and γ-Tocotrienol on promoting
osteoblast differentiation via AMPK signaling. Nat Prod Commun.
17:1–8. 2022.
|
|
58
|
Radzi NFM, Ismail NAS and Alias E:
Tocotrienols regulate bone loss through suppression on osteoclast
differentiation and activity: A systematic review. Curr Drug
Targets. 19:1095–1107. 2018.
|
|
59
|
Ha H, Lee JH, Kim HN and Lee ZH:
α-Tocotrienol inhibits osteoclastic bone resorption by suppressing
RANKL expression and signaling and bone resorbing activity. Biochem
Biophys Res Commun. 406:546–551. 2011.
|
|
60
|
Ormsby RT, Hosaka K, Evdokiou A, Odysseos
A, Findlay DM, Solomon LB and Atkins GJ: The effects of vitamin E
analogues α-Tocopherol and γ-Tocotrienol on the human osteocyte
response to ultra-high molecular weight polyethylene wear
particles. Prosthesis. 4:480–489. 2022.
|
|
61
|
Kim KW, Kim BM, Won JY, Min HK, Lee SJ,
Lee SH and Kim HR: Tocotrienol regulates osteoclastogenesis in
rheumatoid arthritis. Korean J Intern Med. 36(Suppl 1): S273–S282.
2021.
|
|
62
|
Wong SK, Chin KY and Ima-Nirwana S: The
effects of tocotrienol on bone peptides in a rat model of
osteoporosis induced by metabolic syndrome: The possible
communication between bone cells. Int J Environ Res Public Health.
16:33132019.
|
|
63
|
Chin KY, Abdul-Majeed S, Fozi NF and
Ima-Nirwana S: Annatto tocotrienol improves indices of bone static
histomorphometry in osteoporosis due to testosterone deficiency in
rats. Nutrients. 6:4974–4983. 2014.
|
|
64
|
Deng L, Ding Y, Peng Y, Wu Y, Fan J, Li W,
Yang R, Yang M and Fu Q: γ-Tocotrienol protects against
ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA
reductase inhibitor. Bone. 67:200–207. 2014.
|
|
65
|
Soelaiman IN, Ming W, Abu Bakar R, Hashnan
NA, Mohd Ali H, Mohamed N, Muhammad N and Shuid AN: Palm
tocotrienol supplementation enhanced bone formation in
oestrogen-deficient rats. Int J Endocrinol. 2012:5328622012.
|
|
66
|
Mohamad NV, Ima-Nirwana S and Chin KY:
Self-emulsified annatto tocotrienol improves bone histomorphometric
parameters in a rat model of oestrogen deficiency through
suppression of skeletal sclerostin level and RANKL/OPG ratio. Int J
Med Sci. 18:3665–3673. 2021.
|
|
67
|
Liang G, Kow ASF, Tham CL, Ho YC and Lee
MT: Ameliorative effect of tocotrienols on
perimenopausal-associated osteoporosis-a review. Antioxidants
(Basel). 11:21792022.
|
|
68
|
Bus K and Szterk A: Relationship between
structure and biological activity of various vitamin K forms.
Foods. 10:31362021.
|
|
69
|
Myneni VD and Mezey E: Regulation of bone
remodeling by vitamin K2. Oral Dis. 23:1021–1028. 2017.
|
|
70
|
Stevenson M, Lloyd-Jones M and Papaioannou
D: Vitamin K to prevent fractures in older women: Systematic review
and economic evaluation. Health Technol Assess. 13:iii–xi. 1–134.
2009.
|
|
71
|
Ma ML, Ma ZJ, He YL, Sun H, Yang B, Ruan
BJ, Zhan WD, Li SX, Dong H and Wang YX: Efficacy of vitamin K2 in
the prevention and treatment of postmenopausal osteoporosis: A
systematic review and meta-analysis of randomized controlled
trials. Front Public Health. 10:9796492022.
|
|
72
|
Zhou M, Han S, Zhang W and Wu D: Efficacy
and safety of vitamin K2 for postmenopausal women with osteoporosis
at a long-term follow-up: Meta-analysis and systematic review. J
Bone Miner Metab. 40:763–772. 2022.
|
|
73
|
Salma, Ahmad SS, Karim S, Ibrahim IM,
Alkreathy HM, Alsieni M and Khan MA: Effect of vitamin K on bone
mineral density and fracture risk in adults: Systematic review and
meta-analysis. Biomedicines. 10:10482022.
|
|
74
|
Hao G, Zhang B, Gu M, Chen C, Zhang Q,
Zhang G and Cao X: Vitamin K intake and the risk of fractures: A
meta-analysis. Medicine (Baltimore). 96:e67252017.
|
|
75
|
Moore AE, Kim E, Dulnoan D, Dolan AL,
Voong K, Ahmad I, Gorska R, Harrington DJ and Hampson G: Serum
vitamin K1 (phylloquinone) is associated with fracture
risk and hip strength in post-menopausal osteoporosis: A
cross-sectional study. Bone. 141:1156302020.
|
|
76
|
O'Connor EM, Grealy G, McCarthy J, Desmond
A, Craig O, Shanahan F and Cashman KD: Effect of phylloquinone
(vitamin K1) supplementation for 12 months on the indices of
vitamin K status and bone health in adult patients with Crohn's
disease. Br J Nutr. 112:1163–1174. 2014.
|
|
77
|
Tsugawa N, Shiraki M, Suhara Y, Kamao M,
Ozaki R, Tanaka K and Okano T: Low plasma phylloquinone
concentration is associated with high incidence of vertebral
fracture in Japanese women. J Bone Miner Metab. 26:79–85. 2008.
|
|
78
|
Yamauchi M, Yamaguchi T, Nawata K, Takaoka
S and Sugimoto T: Relationships between undercarboxylated
osteocalcin and vitamin K intakes, bone turnover, and bone mineral
density in healthy women. Clin Nutr. 29:761–765. 2010.
|
|
79
|
Kuang X, Liu C, Guo X, Li K, Deng Q and Li
D: The combination effect of vitamin K and vitamin D on human bone
quality: A meta-analysis of randomized controlled trials. Food
Funct. 11:3280–3297. 2020.
|
|
80
|
Bolton-Smith C, McMurdo ME, Paterson CR,
Mole PA, Harvey JM, Fenton ST, Prynne CJ, Mishra GD and Shearer MJ:
Two-year randomized controlled trial of vitamin K1 (phylloquinone)
and vitamin D3 plus calcium on the bone health of older women. J
Bone Miner Res. 22:509–519. 2007.
|
|
81
|
Hu L, Ji J, Li D, Meng J and Yu B: The
combined effect of vitamin K and calcium on bone mineral density in
humans: A meta-analysis of randomized controlled trials. J Orthop
Surg Res. 16:5922021.
|
|
82
|
Platonova K, Kitamura K, Watanabe Y,
Takachi R, Saito T, Kabasawa K, Takahashi A, Kobayashi R, Oshiki R,
Solovev A, et al: Dietary calcium and vitamin K are associated with
osteoporotic fracture risk in middle-aged and elderly Japanese
women, but not men: The Murakami cohort study. Br J Nutr.
125:319–328. 2021.
|
|
83
|
Knapen MHJ, Drummen NE, Smit E, Vermeer C
and Theuwissen E: Three-year low-dose menaquinone-7 supplementation
helps decrease bone loss in healthy postmenopausal women.
Osteoporos Int. 24:2499–2507. 2013.
|
|
84
|
Rønn SH, Harsløf T, Pedersen SB and
Langdahl BL: Vitamin K2 (menaquinone-7) prevents age-related
deterioration of trabecular bone microarchitecture at the tibia in
postmenopausal women. Eur J Endocrinol. 175:541–549. 2016.
|
|
85
|
Shiraki M, Shiraki Y, Aoki C and Miura M:
Vitamin K2 (menatetrenone) effectively prevents fractures and
sustains lumbar bone mineral density in osteoporosis. J Bone Miner
Res. 15:515–521. 2000.
|
|
86
|
Su S, He N, Men P, Song C and Zhai S: The
efficacy and safety of menatetrenone in the management of
osteoporosis: A systematic review and meta-analysis of randomized
controlled trials. Osteoporos Int. 30:1175–1186. 2019.
|
|
87
|
Abdel Aziz DM, Saleh HA, Taha NM and
Elbadawy MA: Relation between circulating vitamin K2 level and
osteoporosis in post-menopausal women. QJM: Int J Med. 114(Suppl
1): hcab116–002. 2021.
|
|
88
|
Heiss C, Hoesel LM, Wehr U, Keller T,
Horas U, Meyer C, Rambeck W and Schnettler R: Vitamin K in
combination with other biochemical markers to diagnose
osteoporosis. Biomarkers. 9:479–488. 2004.
|
|
89
|
Li C, Liang C, Kong Z, Su Y, Ren W, Dong
H, Wu Y, Yang N, Liu R, Wu J and Zheng Y: Determination of vitamin
K1, MK-4, MK-7, and D levels in human serum of postmenopausal
osteoporosis women based on high stability LC-MS/MS: MK-7 may be a
new marker of bone metabolism. Ann Nutr Metab. 79:334–342.
2023.
|
|
90
|
Kawana K, Takahashi M, Hoshino H and
Kushida K: Circulating levels of vitamin K1, menaquinone-4, and
menaquinone-7 in healthy elderly Japanese women and patients with
vertebral fractures and patients with hip fractures. Endocr Res.
27:337–343. 2001.
|
|
91
|
El-Morsy AS, Beshir SR, Farrag KAER,
Mohamed MS and Hamam GG: Comparative study on the effect of vitamin
K versus combined Ca and vitamin D administration on the prevention
of experimentally-induced osteoporosis in adult male albino rats.
Egypt J Histol. 34:5–14. 2011.
|
|
92
|
Hara K, Kobayashi M and Akiyama Y: Vitamin
K2 (menatetrenone) inhibits bone loss induced by prednisolone
partly through enhancement of bone formation in rats. Bone.
31:575–581. 2002.
|
|
93
|
Sasaki N, Kusano E, Takahashi H, Ando Y,
Yano K, Tsuda E and Asano Y: Vitamin K2 inhibits
glucocorticoid-induced bone loss partly by preventing the reduction
of osteoprotegerin (OPG). J Bone Miner Metab. 23:41–47. 2005.
|
|
94
|
Jin C, Tan K, Yao Z, Lin BH, Zhang DP,
Chen WK, Mao SM, Zhang W, Chen L, Lin Z, et al: A novel
anti-osteoporosis mechanism of VK2: Interfering with ferroptosis
via AMPK/SIRT1 pathway in Type 2 diabetic osteoporosis. J Agric
Food Chem. 71:2745–2761. 2023.
|
|
95
|
Yamaguchi M, Sugimoto E and Hachiya S:
Stimulatory effect of menaquinone-7 (vitamin K2) on osteoblastic
bone formation in vitro. Mol Cell Biochem. 223:131–137. 2001.
|
|
96
|
Iwamoto D, Masaki C, Shibata Y, Watanabe
C, Nodai T, Munemasa T, Mukaibo T, Kondo Y and Hosokawa R:
Microstructural and mechanical recovery of bone in ovariectomized
rats: The effects of menaquinone-7. J Mech Behav Biomed Mater.
120:1045712021.
|
|
97
|
Katsuyama H, Otsuki T, Tomita M, Fukunaga
M, Fukunaga T, Suzuki N, Saijoh K, Fushimi S and Sunami S:
Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL
and RANK in osteoblastic MC3T3E1 cells. Int J Mol Med. 15:231–236.
2005.
|
|
98
|
Akbulut AC, Wasilewski GB, Rapp N, Forin
F, Singer H, Czogalla-Nitsche KJ and Schurgers LJ: Menaquinone-7
supplementation improves osteogenesis in pluripotent stem cell
derived mesenchymal stem cells. Front Cell Dev Biol.
8:6187602021.
|
|
99
|
Katsuyama H, Saijoh K, Otsuki T, Tomita M,
Fukunaga M and Sunami S: Menaquinone-7 regulates gene expression in
osteoblastic MC3T3E1 cells. Int J Mol Med. 19:279–284. 2007.
|
|
100
|
Gigante A, Brugè F, Cecconi S, Manzotti S,
Littarru GP and Tiano L: Vitamin MK-7 enhances vitamin D3-induced
osteogenesis in hMSCs: Modulation of key effectors in
mineralization and vascularization. J Tissue Eng Regen Med.
9:691–701. 2015.
|
|
101
|
Tang H, Zhu Z, Zheng Z, Wang H, Li C, Wang
L, Zhao G and Wang P: A study of hydrophobins-modified
menaquinone-7 on osteoblastic cells differentiation. Mol Cell
Biochem. 476:1939–1948. 2021.
|
|
102
|
Yamaguchi M and Weitzmann MN: Vitamin K2
stimulates osteoblastogenesis and suppresses osteoclastogenesis by
suppressing NF-κB activation. Int J Mol Med. 27:3–14. 2011.
|
|
103
|
Wang H, Li L, Zhang N and Ma Y: Vitamin K2
improves osteogenic differentiation by inhibiting STAT1 via the
Bcl-6 and IL-6/JAK in C3H10 T1/2 clone 8 cells. Nutrients.
14:29342022.
|
|
104
|
Owen R, Bahmaee H, Claeyssens F and Reilly
GC: Comparison of the anabolic effects of reported osteogenic
compounds on human mesenchymal progenitor-derived osteoblasts.
Bioengineering (Basel). 7:122020.
|
|
105
|
Wang H, Zhang N, Li L, Yang P and Ma Y:
Menaquinone 4 reduces bone loss in ovariectomized mice through dual
regulation of bone remodeling. Nutrients. 13:25702021.
|
|
106
|
Cui Q, Li N, Nie F, Yang F, Li H and Zhang
J: Vitamin K2 promotes the osteogenic differentiation of
periodontal ligament stem cells via the Wnt/β-catenin signaling
pathway. Arch Oral Biol. 124:1050572021.
|
|
107
|
Urayama S, Kawakami A, Nakashima T, Tsuboi
M, Yamasaki S, Hida A, Ichinose Y, Nakamura H, Ejima E, Aoyagi T,
et al: Effect of vitamin K2 on osteoblast apoptosis: Vitamin K2
inhibits apoptotic cell death of human osteoblasts induced by Fas,
proteasome inhibitor, etoposide, and staurosporine. J Lab Clin Med.
136:181–193. 2000.
|
|
108
|
Jiang Y, Lin L, Xin H, Jin Y, Jiang Y and
Xue L: Study on the protective effect of menatetrenone against the
oxidative stress of osteoblasts. J Pharm Pract Serv. 38:523–527.
2020.
|
|
109
|
Cui Y, Zhang W, Yang P, Zhu S, Luo S and
Li M: Menaquinone-4 prevents medication-related osteonecrosis of
the jaw through the SIRT1 signaling-mediated inhibition of cellular
metabolic stresses-induced osteoblast apoptosis. Free Radic Biol
Med. 206:33–49. 2023.
|
|
110
|
Amizuka N, Li M and Maeda T: The interplay
of magnesium and vitamin K2 on bone mineralization. Clin Calcium.
15:57–61. 2005.In Japanese.
|
|
111
|
Cui L, Xu J, Zhang J, Zhang M, Zhang S and
Bai Y: Menaquinone-4 modulates the expression levels of
calcification-associated factors to inhibit calcification of rat
aortic vascular smooth muscle cells in a dose-dependent manner. Exp
Ther Med. 16:3172–3178. 2018.
|
|
112
|
Li W, Zhang S, Liu J, Liu Y and Liang Q:
Vitamin K2 stimulates MC3T3-E1 osteoblast differentiation and
mineralization through autophagy induction. Mol Med Rep.
19:3676–3684. 2019.
|
|
113
|
Chen L, Shi X, Weng SJ, Xie J, Tang JH,
Yan DY, Wang BZ, Xie ZJ, Wu ZY and Yang L: Vitamin K2 can rescue
the dexamethasone-induced downregulation of osteoblast autophagy
and mitophagy thereby restoring osteoblast function in vitro and in
vivo. Front Pharmacol. 11:12092020.
|
|
114
|
Fusaro M, Cianciolo G, Brandi ML, Ferrari
S, Nickolas TL, Tripepi G, Plebani M, Zaninotto M, Iervasi G, La
Manna G, et al: Vitamin K and osteoporosis. Nutrients.
12:36252020.
|
|
115
|
Tabb MM, Sun A, Zhou C, Grün F, Errandi J,
Romero K, Pham H, Inoue S, Mallick S, Lin M, et al: Vitamin K2
regulation of bone homeostasis is mediated by the steroid and
xenobiotic receptor SXR. J Biol Chem. 278:43919–43927. 2003.
|
|
116
|
Ichikawa T, Horie-Inoue K, Ikeda K,
Blumberg B and Inoue S: Steroid and xenobiotic receptor SXR
mediates vitamin K2-activated transcription of extracellular
matrix-related genes and collagen accumulation in osteoblastic
cells. J Biol Chem. 281:16927–16934. 2006.
|
|
117
|
Zhang Y, Weng S, Yin J, Ding H, Zhang C
and Gao Y: Vitamin K2 promotes mesenchymal stem cell
differentiation by inhibiting miR-133a expression. Mol Med Rep.
15:2473–2480. 2017.
|
|
118
|
Takeuchi Y, Suzawa M, Fukumoto S and
Fujita T: Vitamin K(2) inhibits adipogenesis, osteoclastogenesis,
and ODF/RANK ligand expression in murine bone marrow cell cultures.
Bone. 27:769–776. 2000.
|
|
119
|
Jiang Y, Xia T, Xin H, Jin Y, Jiang Y and
Xue L: Effects of vitamin K on osteoblastic bone formation and
osteoclastic bone absorption. J Pharm Pract. 340–345. 2020.
|
|
120
|
Wu WJ, Gao H, Jin JS and Ahn BY: A
comparatively study of menaquinone-7 isolated from Cheonggukjang
with vitamin K1 and menaquinone-4 on osteoblastic cells
differentiation and mineralization. Food Chem Toxicol.
131:1105402019.
|
|
121
|
Kim M, Na W and Sohn C: Vitamin K1
(phylloquinone) and K2 (menaquinone-4) supplementation improves
bone formation in a high-fat diet-induced obese mice. J Clin
Biochem Nutr. 53:108–113. 2013.
|
|
122
|
Koshihara Y, Hoshi K, Okawara R, Ishibashi
H and Yamamoto S: Vitamin K stimulates osteoblastogenesis and
inhibits osteoclastogenesis in human bone marrow cell culture. J
Endocrinol. 176:339–348. 2003.
|
|
123
|
Akiyama Y, Hara K, Tajima T, Murota S and
Morita I: Effect of vitamin K2 (menatetrenone) on osteoclast-like
cell formation in mouse bone marrow cultures. Eur J Pharmacol.
263:181–185. 1994.
|
|
124
|
Yamaguchi M and Ma ZJ: Inhibitory effect
of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and
osteoclastic bone resorption in rat bone tissues in vitro. Mol Cell
Biochem. 228:39–47. 2001.
|
|
125
|
Tsukamoto Y: Studies on action of
menaquinone-7 in regulation of bone metabolism and its preventive
role of osteoporosis. Biofactors. 22:5–19. 2004.
|
|
126
|
Wu WJ, Kim MS and Ahn BY: The inhibitory
effect of vitamin K on RANKL-induced osteoclast differentiation and
bone resorption. Food Funct. 6:3351–3358. 2015.
|
|
127
|
Lee AS, Sung MJ, Son SJ, Han AR, Hong SM
and Lee SH: Effect of menaquinone-4 on receptor activator of
nuclear factor κB ligand-induced osteoclast differentiation and
ovariectomy-induced bone loss. J Med Food. 26:128–134. 2023.
|
|
128
|
Taira H, Fujikawa Y, Kudo O, Itonaga I and
Torisu T: Menatetrenone (vitamin K2) acts directly on circulating
human osteoclast precursors. Calcif Tissue Int. 73:78–85. 2003.
|
|
129
|
Stock M and Schett G: Vitamin K-dependent
proteins in skeletal development and disease. Int J Mol Sci.
22:93282021.
|
|
130
|
Alonso N, Meinitzer A, Fritz-Petrin E,
Enko D and Herrmann M: Role of Vitamin K in bone and muscle
metabolism. Calcif Tissue Int. 112:178–196. 2023.
|
|
131
|
Komori T: Functions of osteocalcin in
bone, pancreas, testis, and muscle. Int J Mol Sci. 21:75132020.
|
|
132
|
Lacombe J and Ferron M:
Gamma-carboxylation regulates osteocalcin function. Oncotarget.
6:19924–19925. 2015.
|
|
133
|
Rasekhi H, Karandish M, Jalali MT,
Mohammad-Shahi M, Zarei M, Saki A and Shahbazian H: The effect of
vitamin K1 supplementation on sensitivity and insulin resistance
via osteocalcin in prediabetic women: A double-blind randomized
controlled clinical trial. Eur J Clin Nutr. 69:891–895. 2015.
|
|
134
|
Hussein AG, Mohamed RH, Shalaby SM and Abd
El Motteleb DM: Vitamin K2 alleviates type 2 diabetes in
rats by induction of osteocalcin gene expression. Nutrition.
47:33–38. 2018.
|
|
135
|
Clemens TL and Karsenty G: The osteoblast:
An insulin target cell controlling glucose homeostasis. J Bone
Miner Res. 26:677–680. 2011.
|
|
136
|
Roumeliotis S, Dounousi E, Eleftheriadis T
and Liakopoulos V: Association of the inactive circulating matrix
Gla protein with vitamin K Intake, calcification, mortality, and
cardiovascular disease: A review. Int J Mol Sci. 20:6282019.
|
|
137
|
Dalmeijer GW, van der Schouw YT, Vermeer
C, Magdeleyns EJ, Schurgers LJ and Beulens JW: Circulating matrix
Gla protein is associated with coronary artery calcification and
vitamin K status in healthy women. J Nutr Biochem. 24:624–628.
2013.
|
|
138
|
Mandatori D, Pelusi L, Schiavone V, Pipino
C, Di Pietro N and Pandolfi A: The dual role of vitamin K2 in
'bone-vascular crosstalk': Opposite effects on bone loss and
vascular calcification. Nutrients. 13:12222021.
|
|
139
|
Fusaro M, Noale M, Viola V, Galli F,
Tripepi G, Vajente N, Plebani M, Zaninotto M, Guglielmi G, Miotto
D, et al: Vitamin K, vertebral fractures, vascular calcifications,
and mortality: VItamin K Italian (VIKI) dialysis study. J Bone
Miner Res. 27:2271–2278. 2012.
|
|
140
|
Delanaye P, Krzesinski JM, Warling X,
Moonen M, Smelten N, Médart L, Pottel H and Cavalier E:
Dephosphorylated-uncarboxylated Matrix Gla protein concentration is
predictive of vitamin K status and is correlated with vascular
calcification in a cohort of hemodialysis patients. BMC Nephrol.
15:1452014.
|
|
141
|
Mandatori D, Pipino C, Di Tomo P,
Schiavone V, Ranieri A, Pantalone S, Di Silvestre S, Di
Pietrantonio N, Ucci M, Palmerini C, et al: Osteogenic
transdifferentiation of vascular smooth muscle cells isolated from
spontaneously hypertensive rats and potential menaquinone-4
inhibiting effect. J Cell Physiol. 234:19761–19773. 2019.
|
|
142
|
Schurgers LJ, Uitto J and Reutelingsperger
CP: Vitamin K-dependent carboxylation of matrix Gla-protein: A
crucial switch to control ectopic mineralization. Trends Mol Med.
19:217–226. 2013.
|
|
143
|
Tesfamariam B: Involvement of vitamin
K-dependent proteins in vascular calcification. J Cardiovasc
Pharmacol Ther. 24:323–333. 2019.
|
|
144
|
Yee MMF, Chin KY, Ima-Nirwana S and Wong
SK: Vitamin A and bone health: A review on current evidence.
Molecules. 26:17572021.
|
|
145
|
Burckhardt P: Vitamin A and bone health.
Nutrition and bone health. Humana Press; New York, NY: pp. 409–421.
2015
|
|
146
|
Navarro-Valverde C, Caballero-Villarraso
J, Mata-Granados JM, Casado-Díaz A, Sosa-Henríquez M, Malouf-Sierra
J, Nogués-Solán X, Rodríguez-Mañas L, Cortés-Gil X,
Delgadillo-Duarte J and Quesada-Gómez JM: High serum retinol as a
relevant contributor to low bone mineral density in postmenopausal
osteoporotic women. Calcif Tissue Int. 102:651–656. 2018.
|
|
147
|
Mata-Granados JM, Cuenca-Acevedo JR, Luque
de Castro MD, Holick MF and Quesada-Gómez JM: Vitamin D
insufficiency together with high serum levels of vitamin A
increases the risk for osteoporosis in postmenopausal women. Arch
Osteoporos. 8:1242013.
|
|
148
|
Zhang X, Huang J, Zhou Y, Hong Z, Lin X,
Chen S, Ye Y and Zhang Z: Vitamin A nutritional status is a key
determinant of bone mass in children. Nutrients. 14:46942022.
|
|
149
|
Tanumihardjo SA, Gannon BM, Kaliwile C,
Chileshe J and Binkley NC: Restricting vitamin A intake increases
bone formation in Zambian children with high liver stores of
vitamin. Arch Osteoporos. 14:722019.
|
|
150
|
Maggio D, Polidori MC, Barabani M, Tufi A,
Ruggiero C, Cecchetti R, Aisa MC, Stahl W and Cherubini A: Low
levels of carotenoids and retinol in involutional osteoporosis.
Bone. 38:244–248. 2006.
|
|
151
|
Yang Z, Zhang Z, Penniston KL, Binkley N
and Tanumihardjo SA: Serum carotenoid concentrations in
postmenopausal women from the United States with and without
osteoporosis. Int J Vitam Nutr Res. 78:105–111. 2008.
|
|
152
|
Balasuriya CND, Larose TL, Mosti MP,
Evensen KAI, Jacobsen GW, Thorsby PM, Stunes AK and Syversen U:
Maternal serum retinol, 25(OH)D and 1,25(OH)2D concentrations
during pregnancy and peak bone mass and trabecular bone score in
adult offspring at 26-year follow-up. PLoS One.
14:e02227122019.
|
|
153
|
Holvik K, Ahmed LA, Forsmo S, Gjesdal CG,
Grimnes G, Samuelsen SO, Schei B, Blomhoff R, Tell GS and Meyer HE:
No increase in risk of hip fracture at high serum retinol
concentrations in community-dwelling older Norwegians: The
Norwegian epidemiologic osteoporosis studies. Am J Clin Nutr.
102:1289–1296. 2015.
|
|
154
|
Zhou P, Shao R, Wang H, Miao J and Wang X:
Dietary vitamin A, C, and E intake and subsequent fracture risk at
various sites: A meta-analysis of prospective cohort studies.
Medicine (Baltimore). 99:e208412020.
|
|
155
|
Rejnmark L, Vestergaard P, Charles P,
Hermann AP, Brot C, Eiken P and Mosekilde L: No effect of vitamin A
intake on bone mineral density and fracture risk in perimenopausal
women. Osteoporos Int. 15:872–880. 2004.
|
|
156
|
de Jonge EA, Kiefte-de Jong JC,
Campos-Obando N, Booij L, Franco OH, Hofman A, Uitterlinden AG,
Rivadeneira F and Zillikens MC: Dietary vitamin A intake and bone
health in the elderly: The Rotterdam study. Eur J Clin Nutr.
69:1360–1368. 2015.
|
|
157
|
Zia-Ul-Haq M, Riaz M and Modhi AO:
Carotenoids and bone health. In: Carotenoids: Structure and
Function in the Human Body. Springer Cham. 697–713. 2021.
|
|
158
|
Dai Z, Wang R, Ang LW, Low YL, Yuan JM and
Koh WP: Protective effects of dietary carotenoids on risk of hip
fracture in men: The Singapore Chinese health study. J Bone Miner
Res. 29:408–417. 2014.
|
|
159
|
Cao WT, Zeng FF, Li BL, Lin JS, Liang YY
and Chen YM: Higher dietary carotenoid intake associated with lower
risk of hip fracture in middle-aged and elderly Chinese: A matched
case-control study. Bone. 111:116–122. 2018.
|
|
160
|
Xu J, Song C, Song X, Zhang X and Li X:
Carotenoids and risk of fracture: A meta-analysis of observational
studies. Oncotarget. 8:2391–2399. 2017.
|
|
161
|
Gao SS and Zhao Y: The effects of
β-carotene on osteoporosis: A systematic review and meta-analysis
of observational studies. Osteoporos Int. 34:627–639. 2023.
|
|
162
|
Zhang ZQ, Cao WT, Liu J, Cao Y, Su YX and
Chen YM: Greater serum carotenoid concentration associated with
higher bone mineral density in Chinese adults. Osteoporos Int.
27:1593–1601. 2016.
|
|
163
|
Hayhoe RPG, Lentjes MAH, Mulligan AA,
Luben RN, Khaw KT and Welch AA: Carotenoid dietary intakes and
plasma concentrations are associated with heel bone ultrasound
attenuation and osteoporotic fracture risk in the European
prospective investigation into cancer and nutrition (EPIC)-Norfolk
cohort. Br J Nutr. 117:1439–1453. 2017.
|
|
164
|
Tanaka K, Tanaka S, Sakai A, Ninomiya T,
Arai Y and Nakamura T: Deficiency of vitamin A delays bone healing
process in association with reduced BMP2 expression after
drill-hole injury in mice. Bone. 47:1006–1012. 2010.
|
|
165
|
Shen Q, Wang X, Bai H, Tan X and Liu X:
Effects of high-dose all-trans retinoic acid on longitudinal bone
growth of young rats. Growth Horm IGF Res. 62:1014462022.
|
|
166
|
Broulík PD, Raška I and Brouliková K:
Prolonged overdose of all-trans retinoic acid enhances bone
sensitivity in castrated mice. Nutrition. 29:1166–1169. 2013.
|
|
167
|
Lionikaite V, Henning P, Drevinge C, Shah
FA, Palmquist A, Wikström P, Windahl SH and Lerner UH: Vitamin A
decreases the anabolic bone response to mechanical loading by
suppressing bone formation. FASEB J. 33:5237–5247. 2019.
|
|
168
|
Weng Z, Wang C, Zhang C, Xu J, Chai Y, Jia
Y, Han P and Wen G: All-trans retinoic acid promotes osteogenic
differentiation and bone consolidation in a rat distraction
osteogenesis model. Calcif Tissue Int. 104:320–330. 2019.
|
|
169
|
Zhang S, Chen X, Hu Y, Wu J, Cao Q, Chen S
and Gao Y: All-trans retinoic acid modulates Wnt3A-induced
osteogenic differentiation of mesenchymal stem cells via activating
the PI3K/AKT/GSK3β signalling pathway. Mol Cell Endocrinol.
422:243–253. 2016.
|
|
170
|
Zhang W, Deng ZL, Chen L, Zuo GW, Luo Q,
Shi Q, Zhang BQ, Wagner ER, Rastegar F, Kim SH, et al: Retinoic
acids potentiate BMP9-induced osteogenic differentiation of
mesenchymal progenitor cells. PLoS One. 5:e119172010.
|
|
171
|
Osathanon T, Manokawinchoke J, Egusa H and
Pavasant P: Notch signaling partly regulates the osteogenic
differentiation of retinoic acid-treated murine induced pluripotent
stem cells. J Oral Sci. 59:405–413. 2017.
|
|
172
|
Dingwall M, Marchildon F, Gunanayagam A,
Louis CS and Wiper-Bergeron N: Retinoic acid-induced Smad3
expression is required for the induction of osteoblastogenesis of
mesenchymal stem cells. Differentiation. 82:57–65. 2011.
|
|
173
|
Wiper-Bergeron N, St-Louis C and Lee JM:
CCAAT/Enhancer binding protein beta abrogates retinoic acid-induced
osteoblast differentiation via repression of Runx2 transcription.
Mol Endocrinol. 21:2124–2135. 2007.
|
|
174
|
Hisada K, Hata K, Ichida F, Matsubara T,
Orimo H, Nakano T, Yatani H, Nishimura R and Yoneda T: Retinoic
acid regulates commitment of undifferentiated mesenchymal stem
cells into osteoblasts and adipocytes. J Bone Miner Metab.
31:53–63. 2013.
|
|
175
|
Cruz ACC, Cardozo FTGS, Magini RS and
Simões CMO: Retinoic acid increases the effect of bone
morphogenetic protein type 2 on osteogenic differentiation of human
adipose-derived stem cells. J Appl Oral Sci. 27:e201803172019.
|
|
176
|
Liu Y, Liu Y, Zhang R, Wang X, Huang F,
Yan Z, Nie M, Huang J, Wang Y, Wang Y, et al: All-trans retinoic
acid modulates bone morphogenic protein 9-induced osteogenesis and
adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin
signaling pathways. Int J Biochem Cell Biol. 47:47–56. 2014.
|
|
177
|
Skillington J, Choy L and Derynck R: Bone
morphogenetic protein and retinoic acid signaling cooperate to
induce osteoblast differentiation of preadipocytes. J Cell Biol.
159:135–146. 2002.
|
|
178
|
Ferreira-Baptista C, Queirós A, Ferreira
R, Fernandes MH, Gomes PS and Colaço B: Retinoic acid induces the
osteogenic differentiation of cat adipose tissue-derived stromal
cells from distinct anatomical sites. J Anat. 242:277–288.
2023.
|
|
179
|
Shao Y, Chen QZ, Zeng YH, Li Y, Ren WY,
Zhou LY, Liu RX, Wu K, Yang JQ, Deng ZL, et al: All-trans retinoic
acid shifts rosiglitazone-induced adipogenic differentiation to
osteogenic differentiation in mouse embryonic fibroblasts. Int J
Mol Med. 38:1693–1702. 2016.
|
|
180
|
Song HM, Nacamuli RP, Xia W, Bari AS, Shi
YY, Fang TD and Longaker MT: High-dose retinoic acid modulates rat
calvarial osteoblast biology. J Cell Physiol. 202:255–262.
2005.
|
|
181
|
Jeradi S and Hammerschmidt M: Retinoic
acid-induced premature osteoblast-to-preosteocyte transitioning has
multiple effects on calvarial development. Development.
143:1205–1216. 2016.
|
|
182
|
Jacobsen C and Craft AM:
Retinoic-acid-induced osteogenesis of hiPSCs. Nat Biomed Eng.
3:504–506. 2019.
|
|
183
|
Sun W, Shi A, Ma D, Bolscher JGM, Nazmi K,
Veerman ECI, Bikker FJ, Lin H and Wu G: All-trans retinoic acid and
human salivary histatin-1 promote the spreading and osteogenic
activities of pre-osteoblasts in vitro. FEBS Open Bio. 10:396–406.
2020.
|
|
184
|
Karakida T, Yui R, Suzuki T, Fukae M and
Oida S: Retinoic acid receptor γ-dependent signaling cooperates
with BMP2 to induce osteoblastic differentiation of C2C12 cells.
Connect Tissue Res. 52:365–372. 2011.
|
|
185
|
Bi W, Gu Z, Zheng Y, Zhang X, Guo J and Wu
G: Heterodimeric BMP-2/7 antagonizes the inhibition of all-trans
retinoic acid and promotes the osteoblastogenesis. PLoS One.
8:e781982013.
|
|
186
|
Roa LA, Bloemen M, Carels CEL, Wagener
FADTG and Von den Hoff JW: Retinoic acid disrupts osteogenesis in
pre-osteoblasts by down-regulating WNT signaling. Int J Biochem
Cell Biol. 116:1055972019.
|
|
187
|
Krutzen CLJM, Roa LA, Bloemen M and Von
den Hoff JW: Excess vitamin a might contribute to submucous
clefting by inhibiting WNT-mediated bone formation. Orthod
Craniofac Res. 26:132–139. 2023.
|
|
188
|
Liu Y, Ma X, Guo J, Lin Z, Zhou M, Bi W,
Liu J, Wang J, Lu H and Wu G: All-trans retinoic acid can
antagonize osteoblastogenesis induced by different BMPs
irrespective of their dimerization types and dose-efficiencies.
Drug Des Devel Ther. 12:3419–3430. 2018.
|
|
189
|
Chen M, Huang HZ, Wang M and Wang AX:
Retinoic acid inhibits osteogenic differentiation of mouse
embryonic palate mesenchymal cells. Birth Defects Res A Clin Mol
Teratol. 88:965–970. 2010.
|
|
190
|
Chen M, Yang X, LI ZM, Liu X, Wang WC and
Huang HZ: Inhibitory effect of all-trans retinoic acid on
osteogenic differentiation of mouse embryonic palate mesenchymal
cells and its possible mechanism. Chin J Pharmacol Toxicol.
29:836–841. 2015.
|
|
191
|
Wang S, Bi W, Liu Y, Cheng J, Sun W, Wu G
and Xu X: The antagonist of retinoic acid receptor α, ER-50891
antagonizes the inhibitive effect of all-trans retinoic acid and
rescues bone morphogenetic protein 2-induced osteoblastogenic
differentiation. Drug Des Devel Ther. 14:297–308. 2020.
|
|
192
|
Nuka S, Sawada N, Iba K, Chiba H, Ishii S
and Mori M: All-trans retinoic acid inhibits dexamethasone-induced
ALP activity and mineralization in human osteoblastic cell line SV
HFO. Cell Struct Funct. 22:27–32. 1997.
|
|
193
|
Ewendt F, Lehmann A, Wodak MF and Stangl
GI: All-trans retinoic acid and beta-carotene increase sclerostin
production in C2C12 myotubes. Biomedicines. 11:14322023.
|
|
194
|
Guo L, Zhang Y, Liu H, Cheng Q, Yang S and
Yang D: All-trans retinoic acid inhibits the osteogenesis of
periodontal ligament stem cells by promoting IL-1β production via
NF-κB signaling. Int Immunopharmacol. 108:1087572022.
|
|
195
|
Ahmed N, Sammons J, Khokher MA and Hassan
HT: Retinoic acid suppresses interleukin 6 production in normal
human osteoblasts. Cytokine. 12:289–293. 2000.
|
|
196
|
Shen CX and Bi WJ: Role of all-trans
retinoic acid in osteogenic differentiation. J Oral Sci Res.
34:1038–1041. 2018.
|
|
197
|
Hu L, Lind T, Sundqvist A, Jacobson A and
Melhus H: Retinoic acid increases proliferation of human osteoclast
progenitors and inhibits RANKL-stimulated osteoclast
differentiation by suppressing RANK. PLoS One. 5:e133052010.
|
|
198
|
Balkan W, Rodríguez-Gonzalez M, Pang M,
Fernandez I and Troen BR: Retinoic acid inhibits NFATc1 expression
and osteoclast differentiation. J Bone Miner Metab. 29:652–661.
2011.
|
|
199
|
Conaway HH, Persson E, Halén M, Granholm
S, Svensson O, Pettersson U, Lie A and Lerner UH: Retinoids inhibit
differentiation of hematopoietic osteoclast progenitors. FASEB J.
23:3526–3538. 2009.
|
|
200
|
Bi W, Liu Y, Guo J, Lin Z, Liu J, Zhou M,
Wismeijer D, Pathak JL and Wu G: All-trans retinoic-acid inhibits
heterodimeric bone morphogenetic protein 2/7-stimulated
osteoclastogenesis, and resorption activity. Cell Biosci.
8:482018.
|
|
201
|
Kindmark A, Melhus H, Ljunghall S and
Ljunggren O: Inhibitory effects of 9-cis and all-trans retinoic
acid on 1,25(OH)2 vitamin D3-induced bone resorption. Calcif Tissue
Int. 57:242–244. 1995.
|
|
202
|
Conaway HH, Pirhayati A, Persson E,
Pettersson U, Svensson O, Lindholm C, Henning P, Tuckermann J and
Lerner UH: Retinoids stimulate periosteal bone resorption by
enhancing the protein RANKL, a response inhibited by monomeric
glucocorticoid receptor. J Biol Chem. 286:31425–31436. 2011.
|
|
203
|
Saneshige S, Mano H, Tezuka K, Kakudo S,
Mori Y, Honda Y, Itabashi A, Yamada T, Miyata K, Hakeda Y, et al:
Retinoic acid directly stimulates osteoclastic bone resorption and
gene expression of cathepsin K/OC-2. Biochem J. 309:721–724.
1995.
|
|
204
|
Lind T, Öhman C, Calounova G, Rasmusson A,
Andersson G, Pejler G and Melhus H: Excessive dietary intake of
vitamin A reduces skull bone thickness in mice. PLoS One.
12:e01762172017.
|
|
205
|
Yamaguchi M: Role of carotenoid
β-cryptoxanthin in bone homeostasis. J Biomed Sci. 19:362012.
|
|
206
|
Uchiyama S and Yamaguchi M:
Beta-cryptoxanthin stimulates cell differentiation and
mineralization in osteoblastic MC3T3-E1 cells. J Cell Biochem.
95:1224–1234. 2005.
|
|
207
|
Yamaguchi M and Weitzmann MN: The bone
anabolic carotenoid beta-cryptoxanthin enhances transforming growth
factor-beta1-induced SMAD activation in MC3T3 preosteoblasts. Int J
Mol Med. 24:671–675. 2009.
|
|
208
|
Yamaguchi M and Weitzmann MN: The bone
anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin
antagonize NF-κB activation in MC3T3 preosteoblasts. Mol Med Rep.
2:641–644. 2009.
|
|
209
|
Yamaguchi M and Weitzmann MN: The bone
anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast
mineralization and suppresses osteoclast differentiation by
antagonizing NF-κB activation. Int J Mol Med. 30:708–712. 2012.
|
|
210
|
Zhu K, Yang C, Dai H, Li J, Liu W, Luo Y,
Zhang X and Wang Q: Crocin inhibits titanium particle-induced
inflammation and promotes osteogenesis by regulating macrophage
polarization. Int Immunopharmacol. 76:1058652019.
|
|
211
|
Kalalinia F, Ghasim H, Amel Farzad S,
Pishavar E, Ramezani M and Hashemi M: Comparison of the effect of
crocin and crocetin, two major compounds extracted from saffron, on
osteogenic differentiation of mesenchymal stem cells. Life Sci.
208:262–267. 2018.
|
|
212
|
Russo C, Ferro Y, Maurotti S, Salvati MA,
Mazza E, Pujia R, Terracciano R, Maggisano G, Mare R, Giannini S,
et al: Lycopene and bone: An in vitro investigation and a pilot
prospective clinical study. J Transl Med. 18:432020.
|
|
213
|
Oliveira GR, Vargas-Sanchez PK, Fernandes
RR, Ricoldi MST, Semeghini MS, Pitol DL, de Sousa LG, Siessere S
and Bombonato-Prado KF: Lycopene influences osteoblast functional
activity and prevents femur bone loss in female rats submitted to
an experimental model of osteoporosis. J Bone Miner Metab.
37:658–667. 2019.
|
|
214
|
Semeghini MS, Scalize PH, Coelho MC,
Fernandes RR, Pitol DL, Tavares MS, de Sousa LG, Coppi AA, Siessere
S and Bombonato-Prado KF: Lycopene prevents bone loss in
ovariectomized rats and increases the number of osteocytes and
osteoblasts. J Anat. 241:729–740. 2022.
|
|
215
|
Odes-Barth S, Khanin M, Linnewiel-Hermoni
K, Miller Y, Abramov K, Levy J and Sharoni Y: Inhibition of
osteoclast differentiation by carotenoid derivatives through
inhibition of the NF-κB pathway. Antioxidants (Basel).
9:11672020.
|
|
216
|
Linnewiel-Hermoni K, Motro Y, Miller Y,
Levy J and Sharoni Y: Carotenoid derivatives inhibit nuclear factor
kappa B activity in bone and cancer cells by targeting key thiol
groups. Free Radic Biol Med. 75:105–120. 2014.
|
|
217
|
Uchiyama S and Yamaguchi M: Inhibitory
effect of beta-cryptoxanthin on osteoclast-like cell formation in
mouse marrow cultures. Biochem Pharmacol. 67:1297–1305. 2004.
|
|
218
|
Hirata N, Ichimaru R, Tominari T,
Matsumoto C, Watanabe K, Taniguchi K, Hirata M, Ma S, Suzuki K,
Grundler FMW, et al: Beta-cryptoxanthin inhibits
lipopolysaccharide-induced osteoclast differentiation and bone
resorption via the suppression of inhibitor of NF-κB kinase
activity. Nutrients. 11:3682019.
|
|
219
|
Uchiyama S and Yamaguchi M:
Beta-cryptoxanthin stimulates apoptotic cell death and suppresses
cell function in osteoclastic cells: Change in their related gene
expression. J Cell Biochem. 98:1185–1195. 2006.
|
|
220
|
Ozaki K, Okamoto M, Fukasawa K, Iezaki T,
Onishi Y, Yoneda Y, Sugiura M and Hinoi E: Daily intake of
β-cryptoxanthin prevents bone loss by preferential disturbance of
osteoclastic activation in ovariectomized mice. J Pharmacol Sci.
129:72–77. 2015.
|
|
221
|
Matsumoto C, Ashida N, Yokoyama S,
Tominari T, Hirata M, Ogawa K, Sugiura M, Yano M, Inada M and
Miyaura C: The protective effects of β-cryptoxanthin on
inflammatory bone resorption in a mouse experimental model of
periodontitis. Biosci Biotechnol Biochem. 77:860–862. 2013.
|
|
222
|
Wang F, Wang N, Gao Y, Zhou Z, Liu W, Pan
C, Yin P, Yu X and Tang M: β-Carotene suppresses osteoclastogenesis
and bone resorption by suppressing NF-κB signaling pathway. Life
Sci. 174:15–20. 2017.
|
|
223
|
Mamun-Or-Rashid ANM, Lucy TT, Yagi M and
Yonei Y: Inhibitory effects of astaxanthin on CML-HSA-induced
inflammatory and RANKL-induced osteoclastogenic gene expression in
RAW 264.7 Cells. Biomedicines. 10:542021.
|
|
224
|
Tominari T, Matsumoto C, Watanabe K,
Hirata M, Grundler FM, Inada M and Miyaura C: Lutein, a carotenoid,
suppresses osteoclastic bone resorption and stimulates bone
formation in cultures. Biosci Biotechnol Biochem. 81:302–306.
2017.
|
|
225
|
Das SK, Ren R, Hashimoto T and Kanazawa K:
Fucoxanthin induces apoptosis in osteoclast-like cells
differentiated from RAW264.7 cells. J Agric Food Chem.
58:6090–6095. 2010.
|
|
226
|
Aghajanian P, Hall S, Wongworawat MD and
Mohan S: The roles and mechanisms of actions of vitamin C in bone:
New developments. J Bone Miner Res. 30:1945–1955. 2015.
|
|
227
|
Morton DJ, Barrett-Connor EL and Schneider
DL: Vitamin C supplement use and bone mineral density in
postmenopausal women. J Bone Miner Res. 16:135–140. 2001.
|
|
228
|
Malmir H, Shab-Bidar S and Djafarian K:
Vitamin C intake in relation to bone mineral density and risk of
hip fracture and osteoporosis: A systematic review and
meta-analysis of observational studies. Br J Nutr. 119:847–858.
2018.
|
|
229
|
Zeng LF, Luo MH, Liang GH, Yang WY, Xiao
X, Wei X, Yu J, Guo D, Chen HY, Pan JK, et al: Can dietary intake
of vitamin C-oriented foods reduce the risk of osteoporosis,
fracture, and BMD loss? Systematic review with meta-analyses of
recent studies. Front Endocrinol (Lausanne). 10:8442020.
|
|
230
|
Sun Y, Liu C, Bo Y, You J, Zhu Y, Duan D,
Cui H and Lu Q: Dietary vitamin C intake and the risk of hip
fracture: A dose-response meta-analysis. Osteoporos Int. 29:79–87.
2018.
|
|
231
|
Sahni S, Hannan MT, Gagnon D, Blumberg J,
Cupples LA, Kiel DP and Tucker KL: Protective effect of total and
supplemental vitamin C intake on the risk of hip fracture-a 17-year
follow-up from the Framingham osteoporosis study. Osteoporos Int.
20:1853–1861. 2009.
|
|
232
|
Kim YA, Kim KM, Lim S, Choi SH, Moon JH,
Kim JH, Kim SW, Jang HC and Shin CS: Favorable effect of dietary
vitamin C on bone mineral density in postmenopausal women (KNHANES
IV, 2009): Discrepancies regarding skeletal sites, age, and vitamin
D status. Osteoporos Int. 26:2329–2337. 2015.
|
|
233
|
Rondanelli M, Peroni G, Fossari F, Vecchio
V, Faliva MA, Naso M, Perna S, D Paolo E, Riva A, Petrangolini G,
et al: Evidence of a positive link between consumption and
supplementation of ascorbic acid and bone mineral density.
Nutrients. 13:10122021.
|
|
234
|
Lan KM, Wang LK, Lin YT, Hung KC, Wu LC,
Ho CH, Chang CY and Chen JY: Suboptimal plasma vitamin C is
associated with lower bone mineral density in young and early
middle-aged men: A retrospective cross-sectional study. Nutrients.
14:35562022.
|
|
235
|
Mangano KM, Noel SE, Dawson-Hughes B and
Tucker KL: Sufficient plasma vitamin C is related to greater bone
mineral density among postmenopausal women from the Boston Puerto
Rican Health Study. J Nutr. 151:3764–3772. 2021.
|
|
236
|
Sakamoto Y and Takano Y: Morphological
influence of ascorbic acid deficiency on endochondral ossification
in osteogenic disorder Shionogi rat. Anat Rec. 268:93–104.
2002.
|
|
237
|
Hasegawa T, Li M, Hara K, Sasaki M, Tabata
C, de Freitas PH, Hongo H, Suzuki R, Kobayashi M, Inoue K, et al:
Morphological assessment of bone mineralization in tibial
metaphyses of ascorbic acid-deficient ODS rats. Biomed Res.
32:259–269. 2011.
|
|
238
|
Segawa T, Miyakoshi N, Kasukawa Y, Aonuma
H, Tsuchie H and Shimada Y: Combined treatment with minodronate and
vitamin C increases bone mineral density and strength in vitamin
C-deficient rats. Osteoporos Sarcopenia. 2:30–37. 2016.
|
|
239
|
Zhu LL, Cao J, Sun M, Yuen T, Zhou R, Li
J, Peng Y, Moonga SS, Guo L, Mechanick JI, et al: Vitamin C
prevents hypogonadal bone loss. PLoS One. 7:e470582012.
|
|
240
|
Deyhim F, Strong K, Deyhim N, Vandyousefi
S, Stamatikos A and Faraji B: Vitamin C reverses bone loss in an
osteopenic rat model of osteoporosis. Int J Vitam Nutr Res.
88:58–64. 2018.
|
|
241
|
Park JK, Lee EM, Kim AY, Lee EJ, Min CW,
Kang KK, Lee MM and Jeong KS: Vitamin C deficiency accelerates bone
loss inducing an increase in PPAR-γ expression in SMP30 knockout
mice. Int J Exp Pathol. 93:332–340. 2012.
|
|
242
|
Hadzir SN, Ibrahim SN, Abdul Wahab RM,
Zainol Abidin IZ, Senafi S, Ariffin ZZ, Abdul Razak M and Zainal
Ariffin SH: Ascorbic acid induces osteoblast differentiation of
human suspension mononuclear cells. Cytotherapy. 16:674–682.
2014.
|
|
243
|
Okajima LS, Martinez EF, Pinheiro IF,
Fonseca Silva AS and Demasi APD: Effect of sodium ascorbyl
phosphate on osteoblast viability and differentiation. J
Periodontal Res. 55:660–666. 2020.
|
|
244
|
Yang HM and Seo HS: Effects of ascorbic
acid on osteoblast differentiation in MC3T3-E1 cells. Soonchunhyang
Med Sci. 19:93–98. 2013.
|
|
245
|
Carinci F, Pezzetti F, Spina AM, Palmieri
A, Laino G, De Rosa A, Farina E, Illiano F, Stabellini G, Perrotti
V and Piattelli A: Effect of vitamin C on pre-osteoblast gene
expression. Arch Oral Biol. 50:481–496. 2005.
|
|
246
|
Ciceri P, Volpi E, Brenna I, Arnaboldi L,
Neri L, Brancaccio D and Cozzolino M: Combined effects of ascorbic
acid and phosphate on rat VSMC osteoblastic differentiation.
Nephrol Dial Transplant. 27:122–127. 2012.
|
|
247
|
Valenti MT, Zanatta M, Donatelli L,
Viviano G, Cavallini C, Scupoli MT and Dalle Carbonare L: Ascorbic
acid induces either differentiation or apoptosis in MG-63
osteosarcoma lineage. Anticancer Res. 34:1617–1627. 2014.
|
|
248
|
Choi HK, Kim GJ, Yoo HS, Song DH, Chung
KH, Lee KJ, Koo YT and An JH: Vitamin C activates
osteoblastogenesis and inhibits osteoclastogenesis via
Wnt/β-catenin/ATF4 signaling pathways. Nutrients. 11:5062019.
|
|
249
|
Burger MG, Steinitz A, Geurts J, Pippenger
BE, Schaefer DJ, Martin I, Barbero A and Pelttari K: Ascorbic acid
attenuates senescence of human osteoarthritic osteoblasts. Int J
Mol Sci. 18:25172017.
|
|
250
|
Son E, Do H, Joo HM and Pyo S: Induction
of alkaline phosphatase activity by L-ascorbic acid in human
osteoblastic cells: A potential role for CK2 and Ikaros. Nutrition.
23:745–753. 2007.
|
|
251
|
Xing W, Pourteymoor S and Mohan S:
Ascorbic acid regulates osterix expression in osteoblasts by
activation of prolyl hydroxylase and ubiquitination-mediated
proteosomal degradation pathway. Physiol Genomics. 43:749–757.
2011.
|
|
252
|
Rosadi I, Indrady FT, Karina K and Hariani
N: Evaluation effects of ascorbic acid leads to activate and induce
osteogenic protein marker expression: In silico and in-vitro study.
Biomed Res Ther. 9:4832–4841. 2022.
|
|
253
|
Pustylnik S, Fiorino C, Nabavi N,
Zappitelli T, da Silva R, Aubin JE and Harrison RE: EB1 levels are
elevated in ascorbic Acid (AA)-stimulated osteoblasts and mediate
cell-cell adhesion-induced osteoblast differentiation. J Biol Chem.
288:22096–22110. 2013.
|
|
254
|
Farhadian N, Miresmaeili A, Azar R,
Zargaran M, Moghimbeigi A and Soheilifar S: Effect of dietary
ascorbic acid on osteogenesis of expanding midpalatal suture in
rats. J Dent (Tehran). 12:39–48. 2015.
|
|
255
|
Rahman F, Bordignon B, Culerrier R,
Peiretti F, Spicuglia S, Djabali M, Landrier JF and Fontes M:
Ascorbic acid drives the differentiation of mesoderm-derived
embryonic stem cells. Involvement of p38 MAPK/CREB and SVCT2
transporter. Mol Nutr Food Res. 61:2017.
|
|
256
|
Rahman F, Al Frouh F, Bordignon B,
Fraterno M, Landrier JF, Peiretti F and Fontes M: Ascorbic acid is
a dose-dependent inhibitor of adipocyte differentiation, probably
by reducing cAMP pool. Front Cell Dev Biol. 2:292014.
|
|
257
|
Takamizawa S, Maehata Y, Imai K, Senoo H,
Sato S and Hata R: Effects of ascorbic acid and ascorbic acid
2-phosphate, a long-acting vitamin C derivative, on the
proliferation and differentiation of human osteoblast-like cells.
Cell Biol Int. 28:255–265. 2004.
|
|
258
|
Mizutani A, Sugiyama I, Kuno E, Matsunaga
S and Tsukagoshi N: Expression of matrix metalloproteinases during
ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. J
Bone Miner Res. 16:2043–2049. 2001.
|
|
259
|
Thaler R, Khani F, Sturmlechner I,
Dehghani SS, Denbeigh JM, Zhou X, Pichurin O, Dudakovic A, Jerez
SS, Zhong J, et al: Vitamin C epigenetically controls osteogenesis
and bone mineralization. Nat Commun. 13:58832022.
|
|
260
|
Xiao XH, Liao EY, Zhou HD, Dai RC, Yuan LQ
and Wu XP: Ascorbic acid inhibits osteoclastogenesis of RAW264.7
cells induced by receptor activated nuclear factor kappaB ligand
(RANKL) in vitro. J Endocrinol Invest. 28:253–260. 2005.
|
|
261
|
Takarada T, Hinoi E, Kambe Y, Sahara K,
Kurokawa S, Takahata Y and Yoneda Y: Osteoblast protects osteoclast
devoid of sodium-dependent vitamin C transporters from oxidative
cytotoxicity of ascorbic acid. Eur J Pharmacol. 575:1–11. 2007.
|
|
262
|
Sanbe T, Tomofuji T, Ekuni D, Azuma T,
Irie K, Tamaki N, Yamamoto T and Morita M: Vitamin C intake
inhibits serum lipid peroxidation and osteoclast differentiation on
alveolar bone in rats fed on a high-cholesterol diet. Arch Oral
Biol. 54:235–240. 2009.
|
|
263
|
Hie M and Tsukamoto I: Vitamin
C-deficiency stimulates osteoclastogenesis with an increase in RANK
expression. J Nutr Biochem. 22:164–171. 2011.
|
|
264
|
Otsuka E, Kato Y, Hirose S and Hagiwara H:
Role of ascorbic acid in the osteoclast formation: Induction of
osteoclast differentiation factor with formation of the
extracellular collagen matrix. Endocrinology. 141:3006–3011.
2000.
|
|
265
|
Tsuneto M, Yamazaki H, Yoshino M, Yamada T
and Hayashi S: Ascorbic acid promotes osteoclastogenesis from
embryonic stem cells. Biochem Biophys Res Commun. 335:1239–1246.
2005.
|
|
266
|
Ragab AA, Lavish SA, Banks MA, Goldberg VM
and Greenfield EM: Osteoclast differentiation requires ascorbic
acid. J Bone Miner Res. 13:970–977. 1998.
|
|
267
|
Noh AL and Yim M: Beta-glycerophosphate
accelerates RANKL-induced osteoclast formation in the presence of
ascorbic acid. Pharmazie. 66:195–200. 2011.
|
|
268
|
Le Nihouannen D, Barralet JE, Fong JE and
Komarova SV: Ascorbic acid accelerates osteoclast formation and
death. Bone. 46:1336–1343. 2010.
|
|
269
|
Rahman S and Baumgartner M: B vitamins:
Small molecules, big effects. J Inherit Metab Dis. 42:579–580.
2019.
|
|
270
|
Dai Z and Koh WP: B-vitamins and bone
health-a review of the current evidence. Nutrients. 7:3322–3346.
2015.
|
|
271
|
Tucker KL, Hannan MT, Qiao N, Jacques PF,
Selhub J, Cupples LA and Kiel DP: Low plasma vitamin B12 is
associated with lower BMD: The Framingham osteoporosis study. J
Bone Miner Res. 20:152–158. 2005.
|
|
272
|
Pawlak R: Vitamin B12 status is a risk
factor for bone fractures among vegans. Med Hypotheses.
153:1106252021.
|
|
273
|
Zhang H, Tao X and Wu J: Association of
homocysteine, vitamin B12, and folate with bone mineral density in
postmenopausal women: A meta-analysis. Arch Gynecol Obstet.
289:1003–1009. 2014.
|
|
274
|
Ouzzif Z, Oumghar K, Sbai K, Mounach A,
Derouiche M and El Maghraoui A: Relation of plasma total
homocysteine, folate and vitamin B12 levels to bone mineral density
in Moroccan healthy postmenopausal women. Rheumatol Int.
32:123–128. 2012.
|
|
275
|
Wang J, Chen L, Zhang Y, Li CG, Zhang H,
Wang Q, Qi X, Qiao L, Da WW, Cui XJ, et al: Association between
serum vitamin B6 concentration and risk of osteoporosis in the
middle-aged and older people in China: A cross-sectional study. BMJ
Open. 9:e0281292019.
|
|
276
|
Dai Z, Wang R, Ang LW, Yuan JM and Koh WP:
Dietary B vitamin intake and risk of hip fracture: The Singapore
Chinese health study. Osteoporos Int. 24:2049–2059. 2013.
|
|
277
|
Li Z, Zhang S, Wan L, Song X, Yuan D,
Zhang S, Wu D and Jiang J: Vitamin B6 as a novel risk biomarker of
fractured ankles. Medicine (Baltimore). 100:e274422021.
|
|
278
|
Baines M, Kredan MB, Usher J, Davison A,
Higgins G, Taylor W, West C, Fraser WD and Ranganath LR: The
association of homocysteine and its determinants MTHFR genotype,
folate, vitamin B12 and vitamin B6 with bone mineral density in
postmenopausal British women. Bone. 40:730–736. 2007.
|
|
279
|
Rondanelli M, Tartara A, Fossari F,
Vecchio V, Faliva MA, Naso M, Perna S, Nichetti M and Peroni G:
Adequate intake and supplementation of B vitamins, in particular
folic acid, can play a protective role in bone health. Curr Aging
Sci. 15:110–120. 2022.
|
|
280
|
Clements M, Heffernan M, Ward M, Hoey L,
Doherty LC, Hack Mendes R, Clarke MM, Hughes CF, Love I, Murphy S,
et al: A 2-year randomized controlled trial with low-dose B-vitamin
supplementation shows benefits on bone mineral density in adults
with lower B12 status. J Bone Miner Res. 37:2443–2455. 2022.
|
|
281
|
Kalimeri M, Leek F, Wang NX, Koh HR, Roy
NC, Cameron-Smith D, Kruger MC, Henry CJ and Totman JJ: Folate and
vitamin B-12 status is associated with bone mineral density and hip
strength of postmenopausal Chinese-Singaporean women. JBMR Plus.
4:e103992020.
|
|
282
|
Holstein JH, Herrmann M, Splett C,
Herrmann W, Garcia P, Histing T, Graeber S, Ong MF, Kurz K, Siebel
T, et al: Low serum folate and vitamin B6 are associated with an
altered cancellous bone structure in humans. Am J Clin Nutr.
90:1440–1445. 2009.
|
|
283
|
He T, Jin X, Koh YS, Zhang Q, Zhang C and
Liu F: The association of homocysteine, folate, vitamin B12, and
vitamin B6 with fracture incidence in older adults: A systematic
review and meta-analysis. Ann Transl Med. 9:11432021.
|
|
284
|
Haliloglu B, Aksungar FB, Ilter E, Peker
H, Akin FT, Mutlu N and Ozekici U: Relationship between bone
mineral density, bone turnover markers and homocysteine, folate and
vitamin B12 levels in postmenopausal women. Arch Gynecol Obstet.
281:663–668. 2010.
|
|
285
|
Haroon NN, Marwaha RK, Godbole MM and
Gupta SK: Role of B12 and homocysteine status in
determining BMD and bone turnover in young Indians. J Clin
Densitom. 15:366–373. 2012.
|
|
286
|
El Maghraoui A, Ghozlani I, Mounach A,
Rezqi A, Oumghar K, Achemlal L, Bezza A and Ouzzif Z: Homocysteine,
folate, and vitamin B12 levels and vertebral fracture risk in
postmenopausal women. J Clin Densitom. 15:328–333. 2012.
|
|
287
|
Keser I, Ilich JZ, Vrkić N, Giljević Z and
Colić Barić I: Folic acid and vitamin B(12) supplementation lowers
plasma homocysteine but has no effect on serum bone turnover
markers in elderly women: A randomized, double-blind,
placebo-controlled trial. Nutr Res. 33:211–219. 2013.
|
|
288
|
Oliai Araghi S, Kiefte-de Jong JC, van
Dijk SC, Swart KMA, Ploegmakers KJ, Zillikens MC, van Schoor NM, de
Groot LCPGM, Lips P, Stricker BH, et al: Long-term effects of folic
acid and vitamin-B12 supplementation on fracture risk and
cardiovascular disease: Extended follow-up of the B-PROOF trial.
Clin Nutr. 40:1199–1206. 2021.
|
|
289
|
Enneman AW, Swart KM, van Wijngaarden JP,
van Dijk SC, Ham AC, Brouwer-Brolsma EM, van der Zwaluw NL,
Dhonukshe-Rutten RA, van der Cammen TJ, de Groot LC, et al: Effect
of vitamin B12 and folic acid supplementation on bone mineral
density and quantitative ultrasound parameters in older people with
an elevated plasma homocysteine level: B-PROOF, a randomized
controlled trial. Calcif Tissue Int. 96:401–409. 2015.
|
|
290
|
Stone KL, Lui LY, Christen WG, Troen AM,
Bauer DC, Kado D, Schambach C, Cummings SR and Manson JE: Effect of
combination folic acid, vitamin B6, and vitamin
B12 supplementation on fracture risk in women: A
randomized, controlled trial. J Bone Miner Res. 32:2331–2338.
2017.
|
|
291
|
Ahn TK, Kim JO, An HJ, Park HS, Choi UY,
Sohn S, Kim KT, Kim NK and Han IB: 3'-UTR polymorphisms of vitamin
B-related genes are associated with osteoporosis and osteoporotic
vertebral compression fractures (OVCFs) in postmenopausal women.
Genes (Basel). 11:6122020.
|
|
292
|
Liu CT, Karasik D, Xu H, Zhou Y, Broe K,
Cupples LA, Cpgm de Groot L, Ham A, Hannan MT, Hsu YH, et al:
Genetic variants modify the associations of concentrations of
methylmalonic acid, vitamin B-12, vitamin B-6, and folate with bone
mineral density. Am J Clin Nutr. 114:578–587. 2021.
|
|
293
|
He H, Zhang Y, Sun Y, Zhang Y, Xu J, Yang
Y and Chen J: Folic acid attenuates high-fat diet-induced
osteoporosis through the AMPK signaling pathway. Front Cell Dev
Biol. 9:7918802022.
|
|
294
|
Cai H, Lin L, Wang G, Berman Z, Yang X and
Cheng X: Folic acid rescues corticosteroid-induced vertebral
malformations in chick embryos through targeting TGF-β signaling. J
Cell Physiol. 235:8626–8639. 2020.
|
|
295
|
Mohammadi A, Omrani L, Omrani LR, Kiani F,
Eshraghian A, Azizi Z and Omrani GR: Protective effect of folic
acid on cyclosporine-induced bone loss in rats. Transpl Int.
25:127–133. 2012.
|
|
296
|
Su S, Zhang D, Liu J, Zhao H, Tang X, Che
H, Wang Q, Ren W and Zhen D: Folate ameliorates
homocysteine-induced osteoblast dysfunction by reducing endoplasmic
reticulum stress-activated PERK/ATF-4/CHOP pathway in MC3T3-E1
cells. J Bone Miner Metab. 40:422–433. 2022.
|
|
297
|
Santos C, Gomes P, Duarte JA, Almeida MM,
Costa MEV and Fernandes MH: Development of hydroxyapatite
nanoparticles loaded with folic acid to induce osteoblastic
differentiation. Int J Pharm. 516:185–195. 2017.
|
|
298
|
Huot PS, Dodington DW, Mollard RC,
Reza-López SA, Sánchez-Hernández D, Cho CE, Kuk J, Ward WE and
Anderson GH: High folic acid intake during pregnancy lowers body
weight and reduces femoral area and strength in female rat
offspring. J Osteoporos. 2013:1541092013.
|
|
299
|
Singh P, Telnova S, Zhou B, Mohamed AD,
Mello V, Wackerhage H, Guo XE, Panda AK and Yadav VK: Maternal
vitamin B12 in mice positively regulates bone, but not
muscle mass and strength in post-weaning and mature offspring. Am J
Physiol Regul Integr Comp Physiol. 320:R984–R993. 2021.
|
|
300
|
Roman-Garcia P, Quiros-Gonzalez I, Mottram
L, Lieben L, Sharan K, Wangwiwatsin A, Tubio J, Lewis K, Wilkinson
D, Santhanam B, et al: Vitamin B12-dependent taurine
synthesis regulates growth and bone mass. J Clin Invest.
124:2988–3002. 2014.
|
|
301
|
Vaes BLT, Lute C, Blom HJ, Bravenboer N,
de Vries TJ, Everts V, Dhonukshe-Rutten RA, Müller M, de Groot
LCPGM and Steegenga WT: Vitamin B(12) deficiency stimulates
osteoclastogenesis via increased homocysteine and methylmalonic
acid. Calcif Tissue Int. 84:413–422. 2009.
|
|
302
|
Herrmann M, Widmann T, Colaianni G,
Colucci S, Zallone A and Herrmann W: Increased osteoclast activity
in the presence of increased homocysteine concentrations. Clin
Chem. 51:2348–2353. 2005.
|
|
303
|
Shiga T, Kimira Y, Mano H, Kawata T,
Tadokoro T, Suzuki T and Yamamoto Y: Vitamin B12
deficiency-induced increase of osteoclastic bone resorption caused
by abnormal renal resorption of inorganic phosphorus via Napi2a.
Biosci Biotechnol Biochem. 80:510–513. 2016.
|
|
304
|
Massé PG, Delvin EE, Hauschka PV, Donovan
SM, Grynpas MD, Mahuren JD, Watkins BA and Howell DS: Perturbations
in factors that modulate osteoblast functions in vitamin B6
deficiency. Can J Physiol Pharmacol. 78:904–911. 2000.
|
|
305
|
Narisawa S, Wennberg C and Millán JL:
Abnormal vitamin B6 metabolism in alkaline phosphatase knock-out
mice causes multiple abnormalities, but not the impaired bone
mineralization. J Pathol. 193:125–133. 2001.
|
|
306
|
Ma Q, Liang M, Tang X, Luo F and Dou C:
Vitamin B5 inhibit RANKL induced osteoclastogenesis and ovariectomy
induced osteoporosis by scavenging ROS generation. Am J Transl Res.
11:5008–5018. 2019.
|
|
307
|
Cicek B, Hacimuftuoglu A, Yeni Y, Danisman
B, Ozkaraca M, Mokhtare B, Kantarci M, Spanakis M, Nikitovic D,
Lazopoulos G, et al: Chlorogenic acid attenuates
doxorubicin-induced oxidative stress and marks of apoptosis in
cardiomyocytes via Nrf2/HO-1 and dityrosine signaling. J Pers Med.
13:6492023.
|
|
308
|
Ma Q, Liang M, Wang Y, Ding N, Wu Y, Duan
L, Yu T, Lu Y, Xu J, Kang F and Dou C: Non-coenzyme role of vitamin
B1 in RANKL-induced osteoclastogenesis and ovariectomy induced
osteoporosis. J Cell Biochem. 121:3526–3536. 2020.
|
|
309
|
Herrmann M, Schmidt J, Umanskaya N,
Colaianni G, Al Marrawi F, Widmann T, Zallone A, Wildemann B and
Herrmann W: Stimulation of osteoclast activity by low B-vitamin
concentrations. Bone. 41:584–591. 2007.
|
